Cargando…
An High-Throughput In Vivo Screening System to Select H3K4-Specific Histone Demethylase Inhibitors
BACKGROUND: Histone demethylases (HDMs) have a prominent role in epigenetic regulation and are emerging as potential therapeutic cancer targets. The search for small molecules able to inhibit HDMs in vivo is very active but at the present few compounds were found to be specific for defined classes o...
Autores principales: | Mannironi, Cecilia, Proietto, Marco, Bufalieri, Francesca, Cundari, Enrico, Alagia, Angela, Danovska, Svetlana, Rinaldi, Teresa, Famiglini, Valeria, Coluccia, Antonio, La Regina, Giuseppe, Silvestri, Romano, Negri, Rodolfo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3906020/ https://www.ncbi.nlm.nih.gov/pubmed/24489688 http://dx.doi.org/10.1371/journal.pone.0086002 |
Ejemplares similares
-
Small Molecule Inhibitors of KDM5 Histone Demethylases Increase the Radiosensitivity of Breast Cancer Cells Overexpressing JARID1B
por: Pippa, Simone, et al.
Publicado: (2019) -
Mitotic cell death induction by targeting the mitotic spindle with tubulin-inhibitory indole derivative molecules
por: Cesare, Erica Di, et al.
Publicado: (2017) -
A truncated and catalytically inactive isoform of KDM5B histone demethylase accumulates in breast cancer cells and regulates H3K4 tri-methylation and gene expression
por: Di Nisio, Elena, et al.
Publicado: (2023) -
Indolylarylsulfones, a fascinating story of highly potent human immunodeficiency virus type 1 non-nucleoside reverse transcriptase inhibitors
por: Famiglini, Valeria, et al.
Publicado: (2018) -
Focus on Chirality of HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors
por: Famiglini, Valeria, et al.
Publicado: (2016)